Soft tissue cancer, also known as sarcoma, is a type of cancer that develops in the connective tissues of the body, such as the muscles, tendons, fat, and blood vessels. It is typically detected through a combination of diagnostic tests, including imaging scans, biopsies, and blood tests.
Imaging scans are the primary method of detecting soft tissue cancer. Common scans used to detect soft tissue cancer include X-rays, CT scans, MRI scans, PET scans, and ultrasound. These scans allow doctors to visualize the body and look for any unusual growths or lumps that may indicate cancer.
Biopsies are another method of detecting soft tissue cancer. During a biopsy, a sample of cells from the area of concern is removed and examined under a microscope. This can help to determine whether or not the cells are cancerous.
Blood tests can also be used to detect soft tissue cancer. These tests measure the levels of certain proteins and markers in the blood that can be indicators of cancer. However, they are not as reliable as imaging scans or biopsies.
Finally, physical exams and medical history can also help to detect soft tissue cancer. During a physical exam, the doctor will check for any lumps or other abnormalities in the area of concern. Additionally, the doctor may ask questions about any prior medical conditions or treatments that may have put the patient at increased risk for developing soft tissue cancer.
By combining imaging scans, biopsies, blood tests, physical exams, and medical history, doctors are able to detect soft tissue cancer and provide timely treatment.